Marie A. Printz - Concepedia

Author

Marie A. Printz

Halozyme Therapeutics (United States)ORCID

Also Known As

M A Printz, M Printz, M. Printz, Marie A Printz, Marie A. Printz, Marie Printz

Publications

961

Citations

H-Index

Concepts

All Affiliations

Halozyme Therapeutics (United States)Selective Genetics (United States)Rush University Medical Center

About

Marie A. Printz is an author at Halozyme Therapeutics (United States) specializing in medicine, cell proliferation, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	411
2	Health Sciences	2	2	164
3	Cell Biology	2	2	164
4	Engineering	1	1	87
5	Biomedical Engineering	1	1	87

Marie A. Printz

Publications

929

Citations

H-Index

Page 1

	Year	Citations
Engineering of Tooth-Supporting Structures by Delivery of PDGF Gene Therapy Vectors Qiming Jin, Orasa Anusaksathien, Sarah A. Webb, Molecular Therapy	2004	171
AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: Long-term efficacy and tolerability of CERE-120 for Parkinson’s disease Mehdi Gasmi, Eugene P. Brandon, Christopher D. Herzog, Neurobiology of Disease Neurodegenerative DiseasesMedicineNeuropharmacologyNeuroprotectionNeurology	2007	141
Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice. D L Gu, A M Gonzalez, Marie A. Printz, PubMed ImmunologyCell CultureCell ProliferationBasic FgfNumerous Fgfr	1999	103
Matrix Immobilization Enhances the Tissue Repair Activity of Growth Factor Gene Therapy Vectors John A. Doukas, Lois A. Chandler, Ana González, Human Gene Therapy	2001	103
Adenovirus Encoding Human Platelet-Derived Growth Factor-B Delivered in Collagen Exhibits Safety, Biodistribution, and Immunogenicity Profiles Favorable for Clinical Use Danling Gu, Thanh Nguyen, Ana María González-Castro, Molecular Therapy Tissue EngineeringEngineeringWound RepairImmunologyPathology	2004	87
EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO-ASSOCIATED VIRAL VECTOR TYPE 2–MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE-120 FOR PARKINSON'S DISEASE Christopher D. Herzog, Lamar Brown, Dawn Gammon, Neurosurgery	2009	75
Fibroblast Growth Factor 2-Retargeted Adenoviral Vectors Exhibit a Modified Biolocalization Pattern and Display Reduced Toxicity Relative to Native Adenoviral Vectors Marie A. Printz, Ana María González, Mark R. Cunningham, Human Gene Therapy PathologyCell ProliferationCell GrowthTumor BiologyModified Biolocalization Pattern	2000	61
Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration Sanna Rosengren, Samuel S. Dychter, Marie A. Printz, The AAPS Journal	2015	51
Safety of recombinant human hyaluronidase PH20 for subcutaneous drug delivery Stephen P Knowles, Marie A. Printz, David W. Kang, Expert Opinion on Drug Delivery	2021	39
Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays. Marie A. Printz, Julia O. Reynolds, Mento Sj, PubMed	1995	35

Page 1